SG Americas Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85K Sell
500,000
-2,481,400
-83% -$66.1M ﹤0.01% 2966
2025
Q4
$1.14M Buy
2,981,400
+2,681,400
+894% +$67.6M ﹤0.01% 1908
2025
Q3
$33K Sell
300,000
-976,000
-76% -$24.1M ﹤0.01% 3241
2025
Q2
$1.06M Sell
1,276,000
-1,224,000
-49% -$28.5M ﹤0.01% 1148
2025
Q1
$2.37M Buy
2,500,000
+1,989,100
+389% +$52M 0.01% 729
2024
Q4
$18K Sell
510,900
-1,633,000
-76% -$44.3M ﹤0.01% 3019
2024
Q3
$1.42M Buy
2,143,900
+1,743,900
+436% +$50.9M 0.01% 834
2024
Q2
$36K Hold
400,000
﹤0.01% 2727
2024
Q1
$60K Sell
400,000
-1,001,500
-71% -$27.8M ﹤0.01% 2708
2023
Q4
$666K Buy
1,401,500
+1,080,000
+336% +$32.6M 0.01% 1283
2023
Q3
$261K Sell
321,500
-750,000
-70% -$26.5M ﹤0.01% 2154
2023
Q2
$1.91M Buy
1,071,500
+27,600
+3% +$1.07M 0.01% 764
2023
Q1
$860K Buy
1,043,900
+440,000
+73% +$19M 0.01% 1250
2022
Q4
$453K Hold
603,900
0.01% 1623
2022
Q3
$1.43M Sell
603,900
-29,300
-5% -$1.42M 0.02% 783
2022
Q2
$808K Buy
633,200
+12,900
+2% +$657K 0.01% 1496
2022
Q1
$974K Sell
620,300
-58,500
-9% -$3.04M 0.01% 1450
2021
Q4
$964K Sell
678,800
-287,600
-30% -$14.2M 0.01% 1678
2021
Q3
$10.9M Buy
966,400
+837,000
+647% +$37.1M 0.05% 240
2021
Q2
$134K Sell
129,400
-1,602,900
-93% -$62.3M ﹤0.01% 2516
2021
Q1
$437K Sell
1,732,300
-659,900
-28% -$23.4M ﹤0.01% 2104
2020
Q4
$917K Sell
2,392,200
-10,815
-0.5% -$397K ﹤0.01% 1583
2020
Q3
$1.85M Buy
2,403,015
+521,730
+28% +$18.3M 0.01% 780
2020
Q2
$4.23M Buy
1,881,285
+948,600
+102% +$32.2M 0.04% 422
2020
Q1
$4.17M Buy
932,685
+46,060
+5% +$1.57M 0.04% 448
2019
Q4
$1.79M Sell
886,625
-139,339
-14% -$4.96M 0.02% 892
2019
Q3
$3.85M Buy
1,025,964
+558,937
+120% +$20.3M 0.03% 567
2019
Q2
$286K Sell
467,027
-84,320
-15% -$3.35M ﹤0.01% 2224
2019
Q1
$508K Sell
551,347
-366,582
-40% -$14.7M ﹤0.01% 1830
2018
Q4
$285K Buy
917,929
+98,866
+12% +$4.1M ﹤0.01% 2203
2018
Q3
$131K Sell
819,063
-121,210
-13% -$4.67M ﹤0.01% 2756
2018
Q2
$349K Sell
940,273
-139,128
-13% -$4.75M ﹤0.01% 2254
2018
Q1
$761K Sell
1,079,401
-1,431,332
-57% -$49.2M 0.01% 1571
2017
Q4
$404K Buy
2,510,733
+186,558
+8% +$6.36M ﹤0.01% 1985
2017
Q3
$1.08M Buy
2,324,175
+589,502
+34% +$18.9M 0.01% 1201
2017
Q2
$1.8M Buy
1,734,673
+1,122,615
+183% +$35.4M 0.02% 965
2017
Q1
$394K Sell
612,058
-2,724,801
-82% -$85.9M ﹤0.01% 2006
2016
Q4
$6.61M Buy
3,336,859
+607,948
+22% +$18.6M 0.06% 358
2016
Q3
$3.58M Sell
2,728,911
-426,870
-14% -$14.3M 0.04% 459
2016
Q2
$5.08M Buy
3,155,781
+1,170,256
+59% +$37.3M 0.04% 390
2016
Q1
$6.65M Sell
1,985,525
-1,229,491
-38% -$35.1M 0.05% 309
2015
Q4
$5.74M Buy
+3,215,016
New +$101M 0.04% 348
2015
Q3
Sell
-3,500,334
Closed -$5.29M 2558
2015
Q2
$5.29M Buy
3,500,334
+1,084,566
+45% +$35.3M 0.03% 354
2015
Q1
$5.97M Sell
2,415,768
-1,299,477
-35% -$41.3M 0.04% 351
2014
Q4
$16.9M Buy
3,715,245
+200,577
+6% +$5.75M 0.08% 223
2014
Q3
$22.8M Buy
3,514,668
+1,561,079
+80% +$43.8M 0.13% 156
2014
Q2
$12.6M Buy
+1,953,589
New +$55.7M 0.07% 274
2014
Q1
Sell
-1,115,343
Closed -$8K 2705
2013
Q4
$8K Hold
1,115,343
﹤0.01% 2552
2013
Q3
$99K Sell
1,115,343
-105,400
-9% -$2.87M ﹤0.01% 2661
2013
Q2
$1.15M Buy
+1,220,743
New +$33.7M 0.01% 937

Other funds holding PFE

SG Americas Securities's PFE Position: Q1 2026 in Review

SG Americas Securities increased its Pfizer (PFE) stake by 76% in Q1 2026, buying an estimated $109M and bringing the position to 9,513,295 shares worth $267M. The position accounts for 0.29% of the portfolio, ranked #46.

SG Americas Securities first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $353M in Q3 2013. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SG Americas Securities held 9,513,295 shares of Pfizer worth $267M as of Q1 2026.
  • SG Americas Securities bought 4,100,329 Pfizer shares in Q1 2026, an estimated $109M.
  • Pfizer made up 0.29% of SG Americas Securities's portfolio in Q1 2026, its #46 holding.
  • SG Americas Securities first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • SG Americas Securities's Pfizer position peaked at $353M in Q3 2013.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.